- Home
- SCOR vs VRCA Comparison
SCOR vs VRCA Comparison
Compare SCOR & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- VRCA
- Stock Information
- Founded
- SCOR 1999
- VRCA 2013
- Country
- SCOR United States
- VRCA United States
- Employees
- SCOR N/A
- VRCA N/A
- Industry
- SCOR Business Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- VRCA Health Care
- Exchange
- SCOR Nasdaq
- VRCA Nasdaq
- Market Cap
- SCOR 37.1M
- VRCA 40.6M
- IPO Year
- SCOR 2007
- VRCA 2018
- Fundamental
- Price
- SCOR $7.17
- VRCA $3.98
- Analyst Decision
- SCOR
- VRCA Buy
- Analyst Count
- SCOR 0
- VRCA 4
- Target Price
- SCOR N/A
- VRCA $60.00
- AVG Volume (30 Days)
- SCOR 160.8K
- VRCA 356.0K
- Earning Date
- SCOR 11-04-2025
- VRCA 11-06-2025
- Dividend Yield
- SCOR N/A
- VRCA N/A
- EPS Growth
- SCOR N/A
- VRCA N/A
- EPS
- SCOR N/A
- VRCA N/A
- Revenue
- SCOR $358,513,000.00
- VRCA $14,704,000.00
- Revenue This Year
- SCOR $3.45
- VRCA $332.45
- Revenue Next Year
- SCOR $2.59
- VRCA $12.85
- P/E Ratio
- SCOR N/A
- VRCA N/A
- Revenue Growth
- SCOR N/A
- VRCA 5.72
- 52 Week Low
- SCOR $4.39
- VRCA $3.80
- 52 Week High
- SCOR $10.18
- VRCA $17.38
- Technical
- Relative Strength Index (RSI)
- SCOR 45.53
- VRCA 40.39
- Support Level
- SCOR $7.36
- VRCA $3.93
- Resistance Level
- SCOR $7.86
- VRCA $4.54
- Average True Range (ATR)
- SCOR 0.46
- VRCA 0.32
- MACD
- SCOR -0.15
- VRCA -0.01
- Stochastic Oscillator
- SCOR 2.13
- VRCA 22.33
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.